Author Login

Correspondence to Author: Dina Möch, Marlies E. J. Renders, Martin J. Hogdujn, Marc-Hndrik Dalk. 

Polytechnic Institute of Paris is a public technological university located in Palaiseau, France.

Abstract:

Clinical applications of mesenchymal stromal cells (MSCs) are being thoroughly studied for a number of conditions, including solid organ transplantation, autoimmune and hematological disorders, and bone restoration. Furthermore, a vibrant (paracrine) connection between MSCs and recipients was revealed by growing understanding of their mechanism of action.found new mediators like extracellular vesicles (EVs) and (immune) cells. It has been demonstrated that both paracrine signals and EVs contribute to the actions of MSCs and could either serve as therapeutic alternatives or supplement MSC-based therapies. The numerous facets of MSC-based therapy are covered in this Special Issue of Cells, which also contains reviews and original data papers on preclinical models, clinical research, and MSC manufacturing techniques.After an ischemic stroke, functional rehabilitation alternatives are still scarce. In a preclinical setting, early MSCbased methods have failed to replace dead neurons following stroke events; nonetheless, other characteristics of MSCs, like the release of growth Recent research has discovered several important mediators of their therapeutic impact, including factors near the damaged site, the encouragement of axonal outgrowth, neuro- and angiogenesis, and synaptic remodeling. Physical exercise is another popular therapeutic option for stroke recovery (PE). PE reduces cognitive decline, enhances neuroplasticity, and improves motor dysfunction. Nucci and associates.used noninvasive molecular imaging tools to examine the impact of MSC-based cell treatment and physical exercise training in a mouse stroke model. PE combined with local MSC therapy produced the enhanced ability to perform intricate movements and a quicker rate of symmetry recovery over time [1]

Citation:

Dr.Dina Möch, Therapy Using Mesenchymal Stromal Cells. Journal of Clinical Transplantation 2025.